nifedipine and gw9662

nifedipine has been researched along with gw9662 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Fukami, K; Matsui, T; Okuda, S; Takeuchi, M; Ueda, S; Yamagishi, S2
Guo, F; Hashimoto, R; Itoh, S; Kishi, H; Kobayashi, S; Matsuzaki, M; Umeji, K; Umemoto, S1

Other Studies

5 other study(ies) available for nifedipine and gw9662

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.
    Biochemical and biophysical research communications, 2009, Jul-24, Volume: 385, Issue:2

    Topics: Anilides; Calcium Channel Blockers; Chemokine CCL2; Cytoprotection; Glycation End Products, Advanced; Humans; Mesangial Cells; Nifedipine; PPAR gamma; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Transcription, Genetic

2009
Nifedipine activates PPARgamma and exerts antioxidative action through Cu/ZnSOD independent of blood-pressure lowering in SHRSP.
    Journal of atherosclerosis and thrombosis, 2010, Aug-31, Volume: 17, Issue:8

    Topics: Anilides; Animals; Aorta; Blood Pressure; Calcium Channel Blockers; Cells, Cultured; Endothelium, Vascular; Hypertension; Immunoblotting; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Oxidative Stress; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stroke; Superoxide Dismutase; Superoxides

2010
Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor-gamma activation.
    Biochemical and biophysical research communications, 2010, Jul-23, Volume: 398, Issue:2

    Topics: Anilides; Calcium Channel Blockers; Cells, Cultured; Diabetic Nephropathies; Glycation End Products, Advanced; Humans; Kidney Tubules; Nifedipine; Oxidative Stress; PPAR gamma; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Receptors, Immunologic

2010